John McIlwraith

John McIlwraith, listed as board member, appears in our data through filings on Meridian Bioscience Inc shares, published by SEC (Form 4). We count 9 filings; the first trade dates from 11 August 2016 and the latest from 31 January 2023.

Purchases make up the whole of the open-market record (4 purchases, €91k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 3 share grants and 1 option exercise.

A typical purchase (the median) is worth €22k. Clusters matter here: 2 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The newest entry dates from 31 January 2023: a transaction, in Meridian Bioscience Inc. The last insider purchase was made public on 26 February 2020, 2,429 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.